Stacey C Conroy1, James M Bjork1. 1. Hunter Holmes McGuire Veterans Administration Medical Center, Richmond Virginia USA.
Abstract
PURPOSE OF REVIEW: Rates of suicide and opiate overdose have recently skyrocketed in the United States. In light of impulsivity and impaired motivation common in people with substance use disorders, suicidality is common in addiction. RECENT FINDINGS: Chart review surveys indicate two primary suicidal populations that are important to distinguish for clinical practice and healthcare policy. One group is heavily composed of people with SUDs, in whom chronic compulsive use fosters a numb ambivalence about death (low death intentionality). Many of these individuals with opiate use disorder (OUD) exaggerate suicidality to get prompt psychiatric care to treat the OUD. The second group is composed of those who have co-morbid psychiatric disorders and/or chronic pain who have a higher intent to die consistent with traditionally understood suicide risk factors. SUMMARY: We contend that easier access to outpatient opiate agonist treatment would avoid unnecessary hospitalizations for death-ambivalent OUD patients, and for OUD patients in either group. First line treatment with an opioid agonist has high potential to effectively treat suicidal ideation as a secondary benefit.
PURPOSE OF REVIEW: Rates of suicide and opiate overdose have recently skyrocketed in the United States. In light of impulsivity and impaired motivation common in people with substance use disorders, suicidality is common in addiction. RECENT FINDINGS: Chart review surveys indicate two primary suicidal populations that are important to distinguish for clinical practice and healthcare policy. One group is heavily composed of people with SUDs, in whom chronic compulsive use fosters a numb ambivalence about death (low death intentionality). Many of these individuals with opiate use disorder (OUD) exaggerate suicidality to get prompt psychiatric care to treat the OUD. The second group is composed of those who have co-morbid psychiatric disorders and/or chronic pain who have a higher intent to die consistent with traditionally understood suicide risk factors. SUMMARY: We contend that easier access to outpatient opiate agonist treatment would avoid unnecessary hospitalizations for death-ambivalent OUD patients, and for OUD patients in either group. First line treatment with an opioid agonist has high potential to effectively treat suicidal ideation as a secondary benefit.
Authors: Louis A Giordano; Warren K Bickel; George Loewenstein; Eric A Jacobs; Lisa Marsch; Gary J Badger Journal: Psychopharmacology (Berl) Date: 2002-07-13 Impact factor: 4.530
Authors: E Baca-García; C Diaz-Sastre; E Basurte; R Prieto; A Ceverino; J Saiz-Ruiz; J de Leon Journal: J Clin Psychiatry Date: 2001-07 Impact factor: 4.384
Authors: M Connock; A Juarez-Garcia; S Jowett; E Frew; Z Liu; R J Taylor; A Fry-Smith; E Day; N Lintzeris; T Roberts; A Burls; R S Taylor Journal: Health Technol Assess Date: 2007-03 Impact factor: 4.014
Authors: K Blum; E R Braverman; J M Holder; J F Lubar; V J Monastra; D Miller; J O Lubar; T J Chen; D E Comings Journal: J Psychoactive Drugs Date: 2000-11
Authors: Jennifer Brennan Braden; Mark D Sullivan; G Thomas Ray; Kathleen Saunders; Joseph Merrill; Michael J Silverberg; Carolyn M Rutter; Constance Weisner; Caleb Banta-Green; Cynthia Campbell; Michael Von Korff Journal: Gen Hosp Psychiatry Date: 2009-08-27 Impact factor: 3.238
Authors: Lily A Brown; Cecile M Denis; Anthony Leon; Michael B Blank; Steven D Douglas; Knashawn H Morales; Paul F Crits-Christoph; David S Metzger; Dwight L Evans Journal: Drug Alcohol Depend Date: 2021-04-24 Impact factor: 4.852
Authors: Cecile M Denis; Tiffany Dominique; Peter Smith; Danielle Fiore; Yi-Chien Ku; Angus Culhane; Debora Dunbar; Dana Brown; Menvekeh Daramay; Chelsea Voytek; Knashawn H Morales; Michael B Blank; Paul F Crits-Christoph; Steven D Douglas; Serguei Spitsin; Ian Frank; Krystal Colon-Rivera; Luis J Montaner; David S Metzger; Dwight L Evans Journal: AIDS Behav Date: 2021-01-15
Authors: Francisco A Montiel Ishino; Philip R McNab; Tamika Gilreath; Bonita Salmeron; Faustine Williams Journal: BMC Public Health Date: 2020-11-18 Impact factor: 3.295